Pura Vida Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Pura Vida Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$5.58M	–	324
2021 Q2	$5.58M	Buy	+10,000	New	+$5.07M	0.17%	107
2020 Q2	–	Sell	-11,212	Closed	-$5.47M	–	140
2020 Q1	$5.47M	Buy	+11,212	New	+$4.62M	0.65%	38
2019 Q4	–	Sell	-40,000	Closed	-$11.1M	–	115
2019 Q3	$11.1M	Buy	40,000 +20,000	+100%	+$5.92M	1.9%	23
2019 Q2	$6.26M	Buy	+20,000	New	+$6.66M	0.95%	35
2018 Q1	–	Sell	-5,000	Closed	-$1.88M	–	93
2017 Q4	$1.88M	Buy	+5,000	New	+$2.02M	0.79%	47

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Pura Vida Investments's REGN Position: Q3 2021 in Review

Pura Vida Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 10,000 shares — an estimated $5.58M sold.

Pura Vida Investments first reported a position in REGN in Q4 2017 and held it in 5 quarters. The position peaked at $11.1M in Q3 2019. 1,019 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

Pura Vida Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Pura Vida Investments sold 10,000 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $5.58M.
Pura Vida Investments first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 5 quarters.
Pura Vida Investments's Regeneron Pharmaceuticals position peaked at $11.1M in Q3 2019.
1,019 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.